BioWorld

July 16, 2010

View Archived Issues

A Two-Step Procedure Leads To A One-For-All Flu Vaccine

Read More

Still No Partner; Somaxon Adds Sales Team for Silenor Launch

Read More

Evotec Acquiring DeveloGen for €16M Cash, Shares, Earnouts

Read More

Clinuvel's Former Tan Drug Succeeds in Porphyria Trial

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

FDA Panel Rejects Vivus Obesity Pill Qnexa

GAITHERSBURG, Md. – An FDA panel Thursday said the risks of fetal exposure, increased heart rate, depression and other problems outweighed the benefits of weight loss for Vivus Inc.'s Qnexa (phentermine/topiramate). (BioWorld Today) Read More

Tissue-Bone Firm BioMimetic Raising $40M in Stock Offering

Read More